Evaluation of the European Society of Cardiology Risk Assessment Score in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
Zoe R BrownDylan HansenWendy StevensNava FerdowsiLaura J RossAlannah QuinlivanJoanne SahharGene-Siew NgianDiane ApostolopoulosJennifer G WalkerSusanna ProudmanGim Gee TengAndrea H L LowKathleen MorrisroeMandana NikpourPublished in: Arthritis care & research (2024)
The 2022 ESC risk assessment strategy applied at baseline and follow-up predicts survival in SSc-PAH. Treatment decisions for SSc-PAH should include risk assessments, aiming to achieve low-risk status according to the 2022 ESC guidelines.